German vaccine-maker BioNTech said Monday its earnings would take a hit as demand for its coronavirus jab slowed.
German vaccine-maker BioNTech said Monday its earnings would take a hit as demand for its coronavirus jab slowed. BioNTech, which developed and marketed the first coronavirus vaccine together with the US pharma company Pfizer, said in a statement it would likely write off up to 900 million euros ($948 million) in the third quarter. BioNTech […]
The post Slowing vaccine demand to weigh on BioNTech profits appeared first on Insider Paper.
https://insiderpaper.com/slowing-vaccine-demand-to-weigh-on-biontech-profits/
Comments
0 comment